First Time Loading...

Immunovant Inc
NASDAQ:IMVT

Watchlist Manager
Immunovant Inc Logo
Immunovant Inc
NASDAQ:IMVT
Watchlist
Price: 27.35 USD 0.3%
Updated: Apr 29, 2024

Immunovant Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunovant Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Immunovant Inc
NASDAQ:IMVT
Cash from Financing Activities
$70.9m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Immunovant Inc's Cash from Financing Activities?
Cash from Financing Activities
70.9m USD

Based on the financial report for Mar 31, 2023, Immunovant Inc's Cash from Financing Activities amounts to 70.9m USD.

What is Immunovant Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-22%

Over the last year, the Cash from Financing Activities growth was -65%. The average annual Cash from Financing Activities growth rates for Immunovant Inc have been -22% over the past three years .